D. Porter

Infectious Diseases · Journal of Biological Chemistry · 2020

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom D. Porter trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. A. Ward (in Infectious Diseases)

Papers from D. Porter's perspective

Ordered by how strongly the researchers D. Porter trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys (Nature)
  2. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics (New England Journal of Medicine)
  3. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro (Cell Research)
  4. Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture (Antimicrobial Agents and Chemotherapy)
  5. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection (Proceedings of the National Academy of Sciences of the United States of America)
  6. A hierarchical approach to all‐atom protein loop prediction
  7. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase (Proceedings of the Japan Academy. Series B, Physical and biological sciences)
  8. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus (Journal of Biological Chemistry)
  9. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors (Nature Communications)
  10. On the role of the crystal environment in determining protein side-chain conformations. (Journal of Molecular Biology)

Their papers